Status:
COMPLETED
PET-CT and Circulating Tumor Cells in Colorectal Cancer
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Colorectal Cancer
Metastasis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to identify an early indicator of drug efficacy in patients with advanced colorectal cancer - a prospective evaluation of circulating tumor cells, positron-emission tomogr...
Detailed Description
1. To determine if measuring both tumor metabolic response (via FDG-PET scan) \& circulating tumor cells (CirTC) at 4 weeks after starting treatment, is a better predictor of clinical outcome than mea...
Eligibility Criteria
Inclusion
- Metastatic colorectal cancer patients not received prior drug treatment for metastatic CRC
- Age \>= 18 years
- (ECOG) performance status of 0-2
- Measurable tumor sites by RECIST criteria
- Adequate bone marrow, renal \& hepatic functions
Exclusion
- Patients with diabetes mellitus
- presence of hyperglycemia
- Pregnant or lactating patients
Key Trial Info
Start Date :
June 30 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 27 2017
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT01163305
Start Date
June 30 2010
End Date
April 27 2017
Last Update
May 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong